What is PediaLabs?
PediaLabs is a healthcare service provider specializing in mobile phlebotomy, bringing essential blood draw and laboratory services directly to clients' homes or offices. While primarily focusing on pediatric patients, their expertise extends to all age groups, ensuring a safe and comfortable experience. Beyond core phlebotomy, PediaLabs offers supplementary services including immunizations and DNA testing, alongside phlebotomy training programs. The company's commitment to exceptional customer service and a painless patient experience positions it as a convenient alternative to traditional lab settings.
How much funding has PediaLabs raised?
PediaLabs has raised a total of $50K across 1 funding round:
Debt
$50K
Debt (2025): $50K with participation from Northeast Bank
Key Investors in PediaLabs
Northeast Bank
Northeast Bank is a financial institution that has provided debt financing to PediaLabs, indicating a strategic partnership focused on supporting the company's operational expansion and capital needs.
What's next for PediaLabs?
With the recent influx of substantial expansion capital, PediaLabs is poised for significant growth and operational scaling. This strategic investment, likely at a Series B/C stage, suggests a focus on expanding service areas, enhancing technological infrastructure for mobile operations, and potentially broadening their suite of at-home diagnostic services. The company may also look to increase its training capacity to support a growing network of certified phlebotomists, further solidifying its market presence in convenient healthcare solutions.
See full PediaLabs company page
